Current diagnostics and therapy of the most important forms of systemic amyloidosis

被引:0
|
作者
Beimler, J. [1 ]
Schoenland, S. [1 ]
Blank, N. [1 ]
Kristen, A. V. [1 ]
Hegenbart, U. [1 ]
机构
[1] Univ Klinikum Heidelberg, Amyloidose Zentrum, Neuenheimer Feld 410, D-69120 Heidelberg, Germany
来源
NEPHROLOGE | 2015年 / 10卷 / 04期
关键词
Amyloidosis; Chemotherapy; Renal involvement; Dialysis; Early diagnosis;
D O I
10.1007/s11560-014-0957-y
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Systemic amyloidosis is a rare protein deposition disorder in which diagnosis is often delayed due to the non-specific symptoms at disease onset; however, renal involvement can be detected early during the evaluation of proteinuria. This article gives an overview of current data regarding diagnosis, prognosis and treatment of systemic amyloidosis. Conclusion. The prognosis of this fatal disease has recently improved due to the new diagnostic tools and treatment options; however, early diagnosis plays a crucial role in order to circumvent, e.g. dialysis.
引用
收藏
页码:303 / 309
页数:7
相关论文
共 50 条
  • [31] Current state of total artificial heart therapy and introduction of the most important total artificial heart systems
    Spiliopoulos, Sotirios
    Hergesell, Vera
    Wasler, Andrae
    Dapunt, Otto
    BIOMEDICAL ENGINEERING-BIOMEDIZINISCHE TECHNIK, 2019, 64 (03): : 247 - 250
  • [32] Local vs. systemic pulmonary amyloidosis—impact on diagnostics and clinical management
    Julius-Valentin Baumgart
    Christiane Stuhlmann-Laeisz
    Ute Hegenbart
    Johanna Nattenmüller
    Stefan Schönland
    Sandra Krüger
    Hans-Michael Behrens
    Christoph Röcken
    Virchows Archiv, 2018, 473 : 627 - 637
  • [34] Therapy of ATTR Cardiac Amyloidosis: Current Indications
    Di Lisi, Daniela
    Di Stefano, Vincenzo
    Brighina, Filippo
    Galassi, Alfredo Ruggero
    Novo, Giuseppina
    CURRENT PROBLEMS IN CARDIOLOGY, 2023, 48 (02)
  • [35] Melphalan and dexamethasone is an effective therapy for primary systemic amyloidosis
    Tan, Tow-Shung
    Dispenzieri, Angela
    Lacy, Martha Q.
    Hayman, Suzanne R.
    Buadi, Francis K.
    Zeldenrust, Steven R.
    Lust, John A.
    Russell, Stephen J.
    Dingli, David
    Greipp, Philip R.
    Kyle, Robert A.
    Rajkumar, S. Vincent
    Gertz, Morie A.
    Kumar, Shaji
    BLOOD, 2007, 110 (11) : 1055A - 1056A
  • [36] Pulmonary amyloidosis: Treatment with laser therapy and systemic steroids
    Nugent, AM
    Elliott, H
    McGuigan, JA
    Varghese, G
    RESPIRATORY MEDICINE, 1996, 90 (07) : 433 - 435
  • [37] Current diagnostic and therapy of light chain amyloidosis
    Schoenland, S. O.
    Bochtler, T.
    Kristen, A. V.
    Ho, A. D.
    Hegenbart, U.
    PATHOLOGE, 2009, 30 (03): : 205 - 211
  • [38] Systemic Amyloidosis Recognition, Prognosis, and Therapy: A Systematic Review
    Gertz, Morie A.
    Dispenzieri, Angela
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (01): : 79 - 89
  • [39] Current landscape of clinical management for systemic light chain amyloidosis
    Staron, Andrew
    Sanchorawala, Vaishali
    FUTURE CARDIOLOGY, 2025, 21 (04) : 203 - 205
  • [40] CURRENT THERAPY FOR SYSTEMIC MYCOSIS
    GONZALEZ, CC
    MEDICINA CLINICA, 1983, 81 (13): : 589 - 594